Centrifugal field flow fractionation to improve characterization of drug delivery systems
The CF2000 Centrifugal Field Flow Fractionation system from Postnova Analytics aims to deliver exciting new data
The CF2000 Centrifugal Field Flow Fractionation system from Postnova Analytics aims to deliver exciting new data
Meet the preclinical contract research organization that specializes in the pharmacology of spheroids
To help shape future technologies — and be in with a chance of winning a $500/£400/450 € Amazon Gift Card — cast your vote for the product which made the most difference to the lab in 2019
Services expedite downstream screening time with precision control and complete variant coverage
Making high-value chemicals requires many years and large financial investment
From assay inception to dose response and medicinal chemistry, discover the cutting-edge technology used to identify small molecules with clinical potential, in this SelectScience interview
Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds
GARDP, Eisai and Takeda announce partnership in the search for new antibiotics
Join our free upcoming webinar for expert insight from chromatography experts
The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers
Prof. Patrick Gunning, Thermo Fisher Scientific, LGC and BioTek among those recognized at SelectScience's special 20th Anniversary Awards Party
SelectScience is attending SLAS 2018 in San Diego, USA, where we will host the Scientists’ Choice Awards for Drug Discovery at our special 20th Anniversary Party
To be in with a chance of winning a $500/£400/450 € Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your laboratory in 2017
Scientists across the world share their thoughts on the benefits of being a SelectScience member
Compounds reformatted into separate tube collection to enable more efficient management and hit follow-up
New collection of macrocyclic compounds is designed for hit-finding against difficult targets including antiviral and protein-protein interaction targets.
Find out about Sygnature Discovery’s approach to custom assay development and learn the secrets to their success in accelerating the discovery of new therapeutics